We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
- Authors
Voso, M T; Fabiani, E; Piciocchi, A; Matteucci, C; Brandimarte, L; Finelli, C; Pogliani, E; Angelucci, E; Fioritoni, G; Musto, P; Greco, M; Criscuolo, M; Fianchi, L; Vignetti, M; Santini, V; Hohaus, S; Mecucci, C; Leone, G
- Abstract
A letter to the editor is presented which discusses the prognostic role of TET2 mutations BCL2L10 methylation profiling on patients with high risk of myelodysplastic syndrome with 5-azacytidine.
- Subjects
LETTERS to the editor; METHYLATION; AZACITIDINE; THERAPEUTIC use of antimetabolites; THERAPEUTIC use of antineoplastic agents; PROTEINS; MYELODYSPLASTIC syndromes; SURVIVAL; RESEARCH; GENETIC mutation; RESEARCH methodology; PROGNOSIS; RETROSPECTIVE studies; MEDICAL cooperation; EVALUATION research; DNA methylation; COMPARATIVE studies; DNA-binding proteins
- Publication
Leukemia (08876924), 2011, Vol 25, Issue 12, p1910
- ISSN
0887-6924
- Publication type
letter
- DOI
10.1038/leu.2011.170